2022
DOI: 10.3389/fgene.2022.873764
|View full text |Cite|
|
Sign up to set email alerts
|

m6A Regulatory Gene-Mediated Methylation Modification in Glioma Survival Prediction

Abstract: The median survival of patients with gliomas is relatively short. To investigate the epigenetic mechanisms associated with poor survival, we analyzed publicly available datasets from patients with glioma. This analysis revealed 12 prognosis-related m6A regulatory genes that may be responsible for poor prognosis. These genes may be involved in genomic changes inherent to oxidative phosphorylation, adipogenesis, hedgehog signaling, and Myc signaling. We reconstructed a risk model with univariate and multivariate… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 40 publications
0
5
0
Order By: Relevance
“…Functional studies have shown that m6A regulator-mediated m6A modification serves a major role in glioma progression (28).…”
Section: Discussionmentioning
confidence: 99%
“…Functional studies have shown that m6A regulator-mediated m6A modification serves a major role in glioma progression (28).…”
Section: Discussionmentioning
confidence: 99%
“…An increasing number of studies have focused on the role of RNA m 6 A methylation in the development of various neurological diseases, such as Parkinson’s disease [ 23 ], Alzheimer’s disease [ 24 , 25 ], multiple sclerosis [ 26 ], tumours [ 27 , 28 , 29 ], epilepsy [ 30 ], and neuropsychiatric disorders [ 31 ]. However, to date, there is limited research focusing on the role of RNA m 6 A methylation in TBI and BGA.…”
Section: Discussionmentioning
confidence: 99%
“…More importantly, m6A regulators are abnormally expressed and are extensively involved in the progression of glioma by targeting non-coding RNAs. Moreover, as the most important epigenetic regulators, non-coding RNAs can also affect the function of m6A regulators in glioma [22][23][24]. It has confirmed that m6A can regulate circRNA metabolism, including circRNAs biogenesis, translation, degradation and cellular localization [25].…”
Section: Introductionmentioning
confidence: 87%